Top story from February 22, 2022

CUMULUS Oncology, Europe’s first oncology biotech creation company, has secured a £4.1 million ($5.6 million) investment led by St Andrews-based ...

Facebook
LinkedIn
X

22 February 2022

Subscribe to our Daily Newsletter

Why? Free to subscribe, no paywall, daily business news digest.

The Latest Stories